Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. BROKER RATINGS SUMMARY: Charles Stanley Says Accumulate AstraZeneca

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Charles Stanley Says Accumulate AstraZeneca

Tue, 11th Aug 2015 08:43

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning & Monday:
----------
FTSE 100
----------
CITIGROUP REMOVES ARM HOLDINGS FROM 'CITI FOCUS LIST EUROPE' - 'BUY'
----------
CITIGROUP RAISES RANDGOLD RESOURCES PRICE TARGET TO 4745 (4644) PENCE - 'BUY'
----------
JPMORGAN RAISES TRAVIS PERKINS PRICE TARGET TO 2550 (2300) PENCE - 'OVERWEIGHT'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1575 (1570) PENCE - 'HOLD'
----------
BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 440 (436) PENCE - 'EQUAL WEIGHT'
----------
S&P CAPITAL IQ CUTS SCHRODERS PRICE TARGET TO 3400 (3500) PENCE - 'HOLD'
----------
S&P CAPITAL IQ RAISES INMARSAT TO 'HOLD' ('SELL') - TARGET 1000 (900) PENCE
----------
CHARLES STANLEY CUTS DIRECT LINE TO 'REDUCE' ('HOLD') - TARGET 330 (328) PENCE
----------
CHARLES STANLEY CUTS AVIVA PRICE TARGET TO 590 (615) PENCE - 'HOLD'
----------
CHARLES STANLEY CUTS HSBC PRICE TARGET TO 640 (650) PENCE - 'HOLD'
----------
CHARLES STANLEY RAISES ASTRAZENECA TO 'ACCUMULATE' ('HOLD')
----------
FTSE 250
----------
NUMIS CUTS LADBROKES PRICE TARGET TO 110 (140) PENCE - 'HOLD'
----------
TRADERS: PEEL HUNT RAISES MONEYSUPERMARKET.COM TO 'BUY' ('HOLD')
----------
NOMURA CUTS WILLIAM HILL PRICE TARGET TO 433 (443) PENCE - 'BUY'
----------
NOMURA RAISES BETFAIR PRICE TARGET TO 2094 (1838) PENCE - 'REDUCE'
----------
JPMORGAN CUTS ESURE GROUP PRICE TARGET TO 295 (299) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RESUMES KIER GROUP WITH 'OVERWEIGHT' - TARGET 1638 PENCE
----------
BARCLAYS CUTS ESURE GROUP PRICE TARGET TO 295 (300) PENCE - 'OVERWEIGHT'
----------
TRADERS: KEPLER CHEUVREUX CUTS ULTRA ELECTRONICS TO 'HOLD' ('BUY')
----------
TRADERS: MORGAN STANLEY CUTS KAZ MINERALS TO 'UNDERWEIGHT' ('EQUAL-WEIGHT')
----------
TRADERS: MORGAN STANLEY RAISES BBA AVIATION TO 'EQUAL-WEIGHT' ('UNDERWEIGHT')
----------
RBC CAPITAL MARKETS RAISES BALFOUR BEATTY TO OUTPERFORM FROM SECTOR PERFORM
----------
MAIN MARKET AND AIM
----------
NUMIS CUTS JOHNSTON PRESS PRICE TARGET TO 115 (168) PENCE - 'HOLD'
----------
NUMIS CUTS ROTALA TO 'HOLD' ('ADD') - TARGET 74 (70) PENCE
----------
PANMURE CUTS PARTNERSHIP ASSURANCE TO 'HOLD' ('BUY') - TARGET 165 (175) PENCE
----------
LIBERUM RESUMES ROCKHOPPER EXPLORATION WITH 'BUY' - TARGET 138 PENCE
----------
Cantor Puts UK Mail Group At Hold From Under Review, Cuts Price Target To 450p From 590p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
34567891011

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.